0001354457-19-000094.txt : 20190226
0001354457-19-000094.hdr.sgml : 20190226
20190226102837
ACCESSION NUMBER: 0001354457-19-000094
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20190226
DATE AS OF CHANGE: 20190226
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: MIMEDX GROUP, INC.
CENTRAL INDEX KEY: 0001376339
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 262792552
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35887
BUSINESS ADDRESS:
STREET 1: 1775 W OAK COMMONS COURT, NE
CITY: MARIETTA
STATE: GA
ZIP: 30062
BUSINESS PHONE: (770) 651-9100
MAIL ADDRESS:
STREET 1: 1775 W OAK COMMONS COURT, NE
CITY: MARIETTA
STATE: GA
ZIP: 30062
FORMER COMPANY:
FORMER CONFORMED NAME: Alynx, Co.
DATE OF NAME CHANGE: 20060922
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: The Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
The Nasdaq Stock Market LLC
0001376339
MIMEDX GROUP, INC.
001-35887
1775 West Oak Commons Ct NE
Marietta
GA
GEORGIA
30062
(770) 651-9100
Common Stock
17 CFR 240.12d2-2(b)
Amy Horton
Hearings Advisor
2019-02-26
EX-99.25
2
mdxgdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
February 26, 2019, MiMedx Group, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of MiMedx Group, Inc.
(the Company), effective at the opening of the trading
session on March 8, 2019. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5250(c)(1).
The Company was notified of the Staffs determination on
July 20, 2018. The Company appealed the determination
to a Hearing Panel. Upon review of the information provided
by the Company, the Panel issued a decision dated
September 20, 2018, granting the Company continued listing
pursuant to an exception that included several milestones
that the Company was required to meet, towards the goal
of regaining compliance with Listing Rule 5250(c)(1).
However, the Company was
unable to meet the exception milestones as required.
On November 6, 2018, the Panel issued a final delisting
determination and notified the Company that trading in the Companys
securities would be suspended on November 8, 2018.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company
became final on December 21, 2018.